Inventor

JIANG JIAN-KANG

US10 patents

⚠️ This page may combine multiple inventors who share the name “JIANG JIAN-KANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THOMAS CRAIG J

2 patents

US8841305B2Sep 23, 2014

Activators of the human pyruvate kinase M2 receptor

THOMAS CRAIG J24 citations87

US8937067B2Jan 20, 2015

Activators of human pyruvate kinase

THOMAS CRAIG J0 citations47

CHILDRENS HOSPITAL MED CT

2 patents

US11542261B2Jan 3, 2023

Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

CHILDRENS HOSPITAL MED CT9 citations77

US11254667B2Feb 22, 2022

Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

CHILDRENS HOSPITAL MED CT0 citations44

BRIGHAM & WOMENS HOSPITAL INC

2 patents

US11654147B2May 23, 2023

ALK2 inhibitors and methods for inhibiting BMP signaling

BRIGHAM & WOMENS HOSPITAL INC3 citations69

US11026947B2Jun 8, 2021

ALK2 inhibitors and methods for inhibiting BMP signaling

BRIGHAM & WOMENS HOSPITAL INC4 citations69

US HEALTH

2 patents

US9707230B2Jul 18, 2017

Activators of human pyruvate kinase

US HEALTH0 citations49

US9290512B2Mar 22, 2016

Activators of human pyruvate kinase

US HEALTH0 citations49

UNIV ROCKEFELLER

1 patent

US9303044B2Apr 5, 2016

7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

UNIV ROCKEFELLER8 citations82

BEUTLER JOHN A

1 patent

US8993768B2Mar 31, 2015

Tropolone compounds for treating or preventing retroviral infection

BEUTLER JOHN A0 citations31